Ultragenyx Pharmaceutical Inc. RARE
$15.30
+3.03%
at last close
Financials (TTM)
- Revenue
- $717.21 million
- Net Income
- $-585,969,000
- Net Margin
- -81.70%
- Return on Equity
- 201.36%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- -5.18
- Price / Sales
- 2.10
Over the trailing twelve months, Ultragenyx Pharmaceutical Inc. generated revenue of $717.21 million and net income of $-585,969,000, a net margin of -81.70%.
At the last closing price of $15.30, RARE trades at 2.10 times sales, with a market capitalization of $1.51 billion.
Key Stats
- Last Close
- $15.30
- Market Cap
- $1.51 billion
- 52-Week Range
- $13.81 – $39.89
- Average Volume
- 3.42 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.